Cargando…
P1575: TIKSAGEVIMAB/TSILGAVIMAB: EXPERIENCE OF USE FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19 IN ADULT PATIENTS WITH ONCOHEMATOLOGICAL DISEASES
Autores principales: | Chebykina, Daria, Voloshin, Sergey, Zenina, Marina, Kuvshinov, Alexey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429999/ http://dx.doi.org/10.1097/01.HS9.0000973176.14316.1a |
Ejemplares similares
-
PB2060: THE RESULTS OF A FOUR YEARS LONG OBSERVATION OF APLASTIC AMENIA PATIENTS DEPENDING ON A PROGRAM OF IMMUNOSUPPRESSIVE THERAPY
por: Chebykina, Daria, et al.
Publicado: (2023) -
P1573: EVALUATION OF THE EFFICACY OF SARS-COV-2 VACCINATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING THE ERA OF THE COVID-19 PANDEMIC
por: Куневич, Евгений, et al.
Publicado: (2023) -
PReS13-SPK-1575: Science of pain amplification
por: Howard, RF
Publicado: (2013) -
P1606: CENTRAL VEIN CATHETERISATION IN ONCOHEMATOLOGICAL PATIENTS: COMPLICATION, ASSOCIATED WITH PROCEDURA AND CARE
por: Romanenko, N.
Publicado: (2022) -
1575. Comparison of virologic suppression rates pre-, intra- and postpartum in women with HIV in an underserved US community
por: Gerdes, Elise N, et al.
Publicado: (2023)